We use cookies to give you the best experience on our website. If you continue without changing your settings, this will indicate your consent to receive all cookies on the Amgen website. However, if you would like to, you can change your cookie settings at any time. To find out more, visit our cookie policy Cookie Information for Users.
×
Do you want to link to this External Site and leave Amgenbd.com?
You will be redirected in 5 seconds.
No, Return to Amgenbd.com
Yes, Leave Amgenbd.com
YOU ARE NOW LEAVING THE AMGENBD WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Loading...

World-Class Capabilities

From human genetics and target validation to discovery and development to reaching patients globally, Amgen can leverage innovation at virtually every stage in the process of getting a medicine to market.

Focused Areas of Interest

Amgen seeks licensing opportunities that match our strategy and expand our capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, and discovery research and technology.

Flexible and Innovative Deal Structuring

We work with partners in a variety of ways to make the most of innovations that could deliver tangible benefits to those suffering from serious illness.

World-Class Capabilities

Focused Areas of Interest

Flexible and Innovative Deal Structuring

From human genetics and target validation to discovery and development to reaching patients globally, Amgen can leverage innovation at virtually every stage in the process of getting a medicine to market.

Amgen seeks licensing opportunities that match our strategy and expand our capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, and discovery research and technology.

We work with partners in a variety of ways to make the most of innovations that could deliver tangible benefits to those suffering from serious illness.

Amgen: A Venture Capital Success Story

At Amgen, investing in promising innovation is how we've been successful in the past and how we plan to be successful in the future.

 Read More
Photo used courtesy of Ed Lawrence.

Interested in Partnering With Amgen?

Submit a Project
×

Partnership Opportunities

  1. All disclosures on your part are completely voluntary and our review of your submission neither creates nor implies a confidential, fiduciary, employment or contractual relationship. Amgen owes NO COMPENSATION, COMMISSION, OR ANY OTHER PAYMENT to you as a result of your submission.
  2. All information you are disclosing is non-confidential and non-proprietary. Amgen shall not be liable for any disclosure of any information you submit.
  3. Amgen shall not be obligated to specify the reasons for any decision it makes regarding the submission or to reveal any past or present activities that relate to the submission.
  4. You will not challenge or object, or assist any third party to challenge or object, to any use Amgen may make of your submission and any information contained therein for any purpose, and you expressly waive any rights you may have to do so.
  5. You have read, understand and agree to Amgen’s Website Terms of Use and Privacy Statement.

Confirmation

Thank you. Your submission has been received.

Submit another opportunity

×

Form Submission Error

The server experienced an error. Please email your opportunity to licensingopportunities@amgen.com

×